Cynosure Group LLC Invests $500,000 in Ventas, Inc. $VTR

Cynosure Group LLC bought a new position in shares of Ventas, Inc. (NYSE:VTR) in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor bought 6,461 shares of the real estate investment trust’s stock, valued at approximately $500,000.

Several other large investors have also made changes to their positions in VTR. GoalVest Advisory LLC acquired a new position in shares of Ventas during the 4th quarter worth approximately $26,000. Wiser Advisor Group LLC acquired a new position in shares of Ventas during the 3rd quarter worth approximately $27,000. IFC & Insurance Marketing Inc. acquired a new position in shares of Ventas during the 4th quarter worth approximately $30,000. Elyxium Wealth LLC acquired a new position in shares of Ventas during the 4th quarter worth approximately $33,000. Finally, Manchester Capital Management LLC raised its stake in shares of Ventas by 60.5% during the 4th quarter. Manchester Capital Management LLC now owns 491 shares of the real estate investment trust’s stock worth $38,000 after buying an additional 185 shares during the period. 94.18% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the firm’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the sale, the director directly owned 28,349 shares of the company’s stock, valued at $2,557,079.80. This trade represents a 3.90% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler bought 2,500 shares of the business’s stock in a transaction on Wednesday, June 3rd. The stock was bought at an average cost of $78.81 per share, with a total value of $197,025.00. Following the completion of the purchase, the director directly owned 19,202 shares in the company, valued at approximately $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. 0.53% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several research analysts have recently weighed in on VTR shares. Citigroup upped their target price on Ventas from $96.00 to $100.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. UBS Group boosted their price target on Ventas from $85.00 to $93.00 and gave the stock a “neutral” rating in a research report on Monday, May 4th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and set a $100.00 price target on shares of Ventas in a research report on Tuesday. JPMorgan Chase & Co. boosted their price target on Ventas from $93.00 to $94.00 and gave the stock an “overweight” rating in a research report on Monday, May 11th. Finally, KeyCorp boosted their price target on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research report on Thursday, May 7th. Fifteen analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $96.41.

Ventas Stock Up 0.5%

Shares of VTR opened at $83.85 on Wednesday. Ventas, Inc. has a 52-week low of $61.76 and a 52-week high of $91.06. The company has a market capitalization of $40.76 billion, a PE ratio of 152.46, a price-to-earnings-growth ratio of 1.80 and a beta of 0.71. The stock has a fifty day simple moving average of $85.16 and a two-hundred day simple moving average of $82.56. The company has a quick ratio of 0.25, a current ratio of 0.25 and a debt-to-equity ratio of 0.95.

Ventas (NYSE:VTR) last issued its earnings results on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The company had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the business earned $0.84 earnings per share. The firm’s revenue was up 22.0% compared to the same quarter last year. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. As a group, equities analysts forecast that Ventas, Inc. will post 3.88 EPS for the current year.

Ventas Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th will be paid a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. Ventas’s dividend payout ratio (DPR) is 378.18%.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.